Full-Service Manufacturing Approach

Our Montreal location is a boutique manufacturing hub for in-house ophthalmic products. By choosing a partner that dedicates their focus to doing ophthalmics, your project will receive the detail and care it deserves. Two, three-piece bottle lines at our Montreal location are dedicated to ophthalmic projects, in addition to our sterile ointment filler and vial filling line.

Our services expand outside of manufacturing. Rely on us for full turn-key services with secondary packaging along with all your analytical needs.  We also provide international regulatory support for your product to take it globally. JHS is a full-service CMO that takes pride in seeing the full potential in every project.

Discover Our Ophthalmic Capabilities

Three-Piece Bottles

Schedule time on one of our two filling lines. At high speed, your next sterile solution project can be completed with our fully automatic processes equipped with Restricted Access Barrier System (RABS) and 100% In-Process controls (IPC).

Bulk Capacity

Up to 350 L

Validated for

Traditional three piece bottles: 4, 5, 10, 15 and 30 mL

Preservative-free format: 10 mL

Sterile Ointments

Complete your next sterile ointment project with a manufacturer that values expertise. Learn more about our sterile ointment capabilities.


Learn more about our fill finish capabilities.

Stay Up to Date with JHS

Achieving Large-Scale Ophthalmic Production with Jubilant HollisterStier

At Jubilant HollisterStier, ophthalmic production is a core function of the organization’s manufacturing capabilities. With 40 years of experience, JHS’ manufacturing facility in Montreal, Canada has positioned itself as a leader in the space.

Drug Development

Sterile injectable manufacturing requires much more than available capacity and equipment. This critical stage of the drug manufacturing process, when outsourced, calls for a contract manufacturing organization (CMO) that can prove its value in key areas.

$92M Expansion

Jubilant HollisterStier, a wholly owned subsidiary of ultimate parent company Jubilant Pharmova Limited, announces $92M investment to expand sterile injectable manufacturing capacity at its site in Spokane, WA.

Begin the Manufacturing Process Now

Contact us today to partner with JHS on your next manufacturing project.